Literature DB >> 18068302

Neurotransplantation in mice: the concorde-like position ensures minimal cell leakage and widespread distribution of cells transplanted into the cisterna magna.

Miroslaw Janowski1, Magdalena Kuzma-Kozakiewicz, Donat Binder, Hans-Jörg Habisch, Aleksandra Habich, Barbara Lukomska, Krystyna Domanska-Janik, Albert C Ludolph, Alexander Storch.   

Abstract

The access of transplanted cells to large areas of the CNS is of critical value for cell therapy of chronic diseases associated with widespread neurodegeneration. Intrathecal cell application can match this requirement. Here we describe an efficient method for cell injection into the cisterna magna and the assessment of the cell distribution within subarachnoidal space in mice. In order to maximize cell distribution we applied a "concord-like" position, where the cisterna magna is nearly the highest point of the animal's body. A drop of saline on the needle insertion site avoided the outflow of transplanted cells from subarachnoidal space with CSF during surgery. Twenty-four hours later the preparation of the CNS with an intact dura mater by a suitable dissection technique (described in detail) revealed approx. 80% of the injected cells (100,000 cells per animal) within the subarachnoidal space ranging from the skull base (olfactory nerve to premedullary cisterns) to the IV ventricle, and to both the ventral and dorsal surfaces of the spinal cord. Thus the "concorde-like" position proved to be very useful for intrathecal cell application leading to a widespread cell distribution within the subarachnoidal space.

Entities:  

Mesh:

Year:  2007        PMID: 18068302     DOI: 10.1016/j.neulet.2007.10.050

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Neural stem cell transplantation in experimental contusive model of spinal cord injury.

Authors:  Stephana Carelli; Toniella Giallongo; Claudio Gerace; Anthea De Angelis; Michele D Basso; Anna Maria Di Giulio; Alfredo Gorio
Journal:  J Vis Exp       Date:  2014-12-17       Impact factor: 1.355

2.  Adipose-derived stem cells protect motor neurons and reduce glial activation in both in vitro and in vivo models of ALS.

Authors:  Yuri Ciervo; Noemi Gatto; Chloe Allen; Andrew Grierson; Laura Ferraiuolo; Richard J Mead; Pamela J Shaw
Journal:  Mol Ther Methods Clin Dev       Date:  2021-03-27       Impact factor: 6.698

Review 3.  Genetic Engineering of Mesenchymal Stem Cells to Induce Their Migration and Survival.

Authors:  Adam Nowakowski; Piotr Walczak; Barbara Lukomska; Miroslaw Janowski
Journal:  Stem Cells Int       Date:  2016-05-03       Impact factor: 5.443

4.  SOD1/Rag2 Mice with Low Copy Number of SOD1 Gene as a New Long-Living Immunodeficient Model of ALS.

Authors:  M Majchrzak; K Drela; A Andrzejewska; P Rogujski; S Figurska; M Fiedorowicz; P Walczak; M Janowski; B Lukomska; L Stanaszek
Journal:  Sci Rep       Date:  2019-01-28       Impact factor: 4.379

5.  Manganese-Labeled Alginate Hydrogels for Image-Guided Cell Transplantation.

Authors:  Antonina M Araszkiewicz; Eduarda P Oliveira; Terje Svendsen; Katarzyna Drela; Piotr Rogujski; Izabela Malysz-Cymborska; Michal Fiedorowicz; Rui L Reis; Joaquim Miguel Oliveira; Piotr Walczak; Miroslaw Janowski; Barbara Lukomska; Luiza Stanaszek
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

6.  Transplantation of Human Glial Progenitors to Immunodeficient Neonatal Mice with Amyotrophic Lateral Sclerosis (SOD1/rag2).

Authors:  Luiza Stanaszek; Piotr Rogujski; Katarzyna Drela; Michal Fiedorowicz; Piotr Walczak; Barbara Lukomska; Miroslaw Janowski
Journal:  Antioxidants (Basel)       Date:  2022-05-26

7.  Long-term MRI cell tracking after intraventricular delivery in a patient with global cerebral ischemia and prospects for magnetic navigation of stem cells within the CSF.

Authors:  Miroslaw Janowski; Piotr Walczak; Tomasz Kropiwnicki; Elzbieta Jurkiewicz; Krystyna Domanska-Janik; Jeff W M Bulte; Barbara Lukomska; Marcin Roszkowski
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.